Rebecca Araujo

Rebecca Araujo

Articles by Rebecca Araujo

Rebecca AraujoLiver Cancer | March 19, 2025
Atezolizumab plus bevacizumab improves recurrence-free survival in patients with resected or ablated high-risk HCC.
Read More
Rebecca AraujoLiver Cancer | March 19, 2025
TACE in combination with TKIs and ICIs led to improvements in response and survival in patients with HCC.
Rebecca AraujoLiver Cancer | March 19, 2025
A study sought to understand the prognostic ability of 2 angiogenesis mediators to predict poor response to TACE in HCC.
Rebecca AraujoLiver Cancer | March 19, 2025
A study evaluated predictors of liver segmental hypertrophy following radiotherapy for metastatic liver cancer.
Rebecca AraujoLiver Cancer | March 19, 2025
A treatment combination significantly improved survival for the treatment of HCC in patients who are refractory to TACE.
Rebecca AraujoColorectal Cancer | March 19, 2025
A study evaluated 6 clinical trials of HER2-targeted regimens of HER2-positive metastatic colorectal cancer.
Rebecca AraujoLiver Cancer | March 19, 2025
A study assessed the efficacy of of several adjuvant therapies for hepatocellular carcinoma.
Rebecca AraujoColorectal Cancer | March 19, 2025
A study assessed whether the addition of anti-VEGF agent to first-line treatment impacted outcomes in metastatic CRC.
Rebecca AraujoColorectal Cancer | September 18, 2023
A study assessed the efficacy of a treatment combination in the second-line treatment of metastatic colorectal cancer.
Rebecca AraujoColorectal Cancer | September 14, 2023
A systematic review reported that immune checkpoint inhibitor therapy shows promising results in metastatic CRC.
Rebecca AraujoPancreatic Cancer | March 19, 2025
Nimotuzumab plus gemcitabine demonstrated a favorable safety profile in patients with metastatic pancreatic cancer.
Rebecca AraujoGI Cancer | March 19, 2025
Daily vitamin D3 supplementation was associated with reduced risk of relapse or death in digestive tract cancer.
Rebecca AraujoGastric Cancer | March 19, 2025
A study evaluated the predictive ability of the combined SMI and PNI to assess survival in advanced gastric cancer patients.
Rebecca AraujoColorectal Cancer | March 19, 2025
Treatment with avelumab improved progression-free survival in patients with mCRC.
Rebecca AraujoEsophageal Cancer | March 19, 2025
Preoperative induction chemotherapy followed by chemoradiotherapy prior to esophagectomy does not improve survival.
Rebecca AraujoGastric Cancer | March 19, 2025
A study found that adding docetaxel to S-1 as postoperative chemotherapy improves survival in gastric cancer patients.
Rebecca AraujoGI Cancer | August 7, 2023
A study investigated whether BMI is related to postoperative opioid use after treatment for peritoneal carcinomatosis.
Rebecca AraujoColorectal Cancer | March 19, 2025
A novel classification system for molecular subtypes of colorectal liver metastasis was found to be linked with prognosis.
Rebecca AraujoLiver Cancer | January 13, 2022
The American Society for Radiation Oncology (ASTRO) released a new guideline regarding external beam radiation therapy ...
Rebecca AraujoGastric Cancer | March 19, 2025
Incidence of gastric cancer has increased in people aged ≤40 years since 1980 in some countries, according to a new ...